Evan Shlofmitz, DO, director of intravascular imaging at St. Francis Hospital, explains how advanced artificial intelligence technology is used to assess a patient's CT scan before they undergo PCI.

The biggest differences, researchers noted, were found in the long-term outcomes of low- and intermediate-risk patients.

Pi-Cardia, an Israeli medtech company, describes ShortCut as the “world’s first dedicated leaflet modification device."

The new-look Javelin Peripheral IVL Catheter was designed to travel through extremely narrowed blood vessels and target plaques with up to 120 pulses.

Hospitals that partner with either company will now experience the benefits of both, learning more about the long-term heart health of their patients than ever before.

Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately. 

The American College of Cardiology and American Heart Association published the new guidelines with assistance from other leading U.S. medical societies. 

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed. 

Researchers used advanced AI to see if any FDA-approved medications could potentially reverse one of the mutations behind dilated cardiomyopathy. Risedronate, a popular osteoporosis medication, is the one candidate that got the job done.

Military veterans face an increased risk of cardiovascular disease, making it especially important to ensure they receive high-quality care.

Dermatologists increasingly rely on medical imaging modalities—especially but not solely ultrasound—to help diagnose complex and diverse skin disorders. 

That number could rise to $6.75 million, depending on the number of patients who sign onto the class-action settlement levied against Virginia Mason Medical Center. The hospital does not admit to wrongdoing.